JPH0322878B2 - - Google Patents

Info

Publication number
JPH0322878B2
JPH0322878B2 JP61038135A JP3813586A JPH0322878B2 JP H0322878 B2 JPH0322878 B2 JP H0322878B2 JP 61038135 A JP61038135 A JP 61038135A JP 3813586 A JP3813586 A JP 3813586A JP H0322878 B2 JPH0322878 B2 JP H0322878B2
Authority
JP
Japan
Prior art keywords
tetrahydro
thienyl
oxo
carbonyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61038135A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61227579A (ja
Inventor
Cheshi Paoro
Serubajio Bitsutorino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHESHI PHARM SpA
Original Assignee
CHESHI PHARM SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHESHI PHARM SpA filed Critical CHESHI PHARM SpA
Publication of JPS61227579A publication Critical patent/JPS61227579A/ja
Publication of JPH0322878B2 publication Critical patent/JPH0322878B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP61038135A 1985-02-22 1986-02-21 ホモシステインチオラクトン誘導体、その製法およびそれを含有する医薬 Granted JPS61227579A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19621A/85 1985-02-22
IT8519621A IT1215238B (it) 1985-02-22 1985-02-22 Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche

Publications (2)

Publication Number Publication Date
JPS61227579A JPS61227579A (ja) 1986-10-09
JPH0322878B2 true JPH0322878B2 (enExample) 1991-03-27

Family

ID=11159747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61038135A Granted JPS61227579A (ja) 1985-02-22 1986-02-21 ホモシステインチオラクトン誘導体、その製法およびそれを含有する医薬

Country Status (8)

Country Link
US (1) US4690944A (enExample)
EP (1) EP0192191B1 (enExample)
JP (1) JPS61227579A (enExample)
AT (1) ATE42287T1 (enExample)
DE (1) DE3662887D1 (enExample)
ES (1) ES8708134A1 (enExample)
IT (1) IT1215238B (enExample)
PT (1) PT82071B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254530B (it) * 1992-03-18 1995-09-25 Derivati mercapto acetamidici
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
ES2061398B1 (es) * 1993-03-02 1996-02-16 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir del dl-homocistina por metodos electroquimicos.
ES2061397B1 (es) * 1993-03-02 1996-02-16 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir de nn-acetil homocistina por metodos electroquimicos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2129877B1 (enExample) * 1971-03-18 1974-08-02 Fuveau Sa
FR2265355B1 (enExample) * 1974-03-28 1977-11-04 Blum Jean
IT1068217B (it) * 1976-10-14 1985-03-21 Sigma Tau Ind Farmaceuti Omocisteina tiolattone 6 cloro nicotinamide
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
IT8519621A0 (it) 1985-02-22
ES8708134A1 (es) 1987-09-16
ATE42287T1 (de) 1989-05-15
US4690944A (en) 1987-09-01
JPS61227579A (ja) 1986-10-09
EP0192191B1 (en) 1989-04-19
EP0192191A1 (en) 1986-08-27
PT82071A (en) 1986-03-01
IT1215238B (it) 1990-01-31
DE3662887D1 (en) 1989-05-24
ES552281A0 (es) 1987-09-16
PT82071B (pt) 1987-12-30

Similar Documents

Publication Publication Date Title
EP0506532B1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
US6515124B2 (en) Dehydroamino acids
JPS63159385A (ja) マロン酸誘導体及びその製法並びにその用途
TW201442702A (zh) 包含硝醯基予體的醫藥組合物
AU2001230227A1 (en) Dehydroamino acids
EP1529041B1 (de) Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
JP2010504940A (ja) スルホンアミド誘導体
US20080139607A1 (en) New Compounds
DE3784835T2 (de) Chinoxalinon-derivate.
JPH0322878B2 (enExample)
JPH07267954A (ja) 新規の３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１ノナン−化合物、その製法及び抗不整脈剤
FR2505834A1 (fr) Derives de la thiazolidine
JPS62120375A (ja) チアゾリジン誘導体、その製法および医薬組成物
HU181608B (en) Process for producing imidazo-thieno-pyrimidine derivatives
WO2019232664A1 (zh) 一类具有消炎免疫活性的磺酰基取代呋喃类化合物及其衍生物
US4416891A (en) Ester of 6-[(hexahydro-1H-azepin-1-yl)methyleneamino]penicillanic acid, and its use as antibacterial agent
CA1164862A (en) Indol acetic derivates, process for producing the same and pharmaceutical compositions comprising the same
JP3049284B2 (ja) ヒダントイン誘導体並びにそれを有効成分とする糖尿病合併症及び循環器系疾患の予防及び治療剤
WO2019232665A1 (zh) 一类具有抗癌活性的硫代吲嗪类化合物及其衍生物
JP4011780B2 (ja) ジヒドロキノリン誘導体
JPH04505920A (ja) 治療用ヌクレオシド
KR20240049517A (ko) 퀴놀린 메르캅토아세테이트 설폰아미드 유도체, 중간체, 약학적 유도체 또는 제형 및 이의 제조 방법 및 용도
TW202317095A (zh) ２－氧代－３－氮雜雙環［３．１．０］己烷衍生物
CN118063450A (zh) 芳基磺酰胺类化合物及其制法和药物用途
CN116535340A (zh) 取代n-芳基-1-萘胺类化合物及其制法和药物用途